- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04260750
ICBT for Depression - A Factorial Investigation of Kinds of Therapist Support and Self-/Expert-selected Content
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Östergötland
-
Linköping, Östergötland, Sweden, 58330
- Linköping University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Current depressive symptoms equivalent to a score of at least 5 on Patient Health Questionnaire 9 and a minimum of 10 points on Becks Depression Inventory.
- 18 years or older.
- Adequate ability to understand and speak Swedish.
- Access to the internet and a smartphone/computer.
Exclusion Criteria:
- Other ongoing psychological treatment or counselling.
- Recent (within the past 3 months) changes in the dose of psychotropic medication.
- Prior diagnosis of psychosis, bipolar disorder, or substance dependence.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Expert-chosen content, regular guidance
Content chosen by the therapist, weekly guidance by a therapist.
|
The intervention consists of fifteen modules, each having a specific focus on a problem (e.g. comorbid worry alongside the depression) or containing a specific strategy or element (e.g. behavioral activation). The fifteen modules are: Introduction/Psychoeducation about depression, Behavioral activation 1, Behavioral activation 2, Cognitive restructuring, Acceptance, Psychoeducation about emotions, Anxiety and exposure, Comorbid social anxiety, Comorbid worrying and generalized anxiety, Comorbid panic disorder, Sleep problems, Perfectionism, Stress management, Relaxation, and Relapse prevention. The first and last module are assigned to all participants. The rest is picked either by the participants themselves or by the therapist conducting the intake interview. |
|
Experimental: Expert-chosen content, on-demand guidance
Content chosen by the therapist, guidance upon request from the health care team.
|
The intervention consists of fifteen modules, each having a specific focus on a problem (e.g. comorbid worry alongside the depression) or containing a specific strategy or element (e.g. behavioral activation). The fifteen modules are: Introduction/Psychoeducation about depression, Behavioral activation 1, Behavioral activation 2, Cognitive restructuring, Acceptance, Psychoeducation about emotions, Anxiety and exposure, Comorbid social anxiety, Comorbid worrying and generalized anxiety, Comorbid panic disorder, Sleep problems, Perfectionism, Stress management, Relaxation, and Relapse prevention. The first and last module are assigned to all participants. The rest is picked either by the participants themselves or by the therapist conducting the intake interview. |
|
Experimental: Participant-chosen content, regular guidance
Content chosen by participants themselves, weekly guidance by a therapist.
|
The intervention consists of fifteen modules, each having a specific focus on a problem (e.g. comorbid worry alongside the depression) or containing a specific strategy or element (e.g. behavioral activation). The fifteen modules are: Introduction/Psychoeducation about depression, Behavioral activation 1, Behavioral activation 2, Cognitive restructuring, Acceptance, Psychoeducation about emotions, Anxiety and exposure, Comorbid social anxiety, Comorbid worrying and generalized anxiety, Comorbid panic disorder, Sleep problems, Perfectionism, Stress management, Relaxation, and Relapse prevention. The first and last module are assigned to all participants. The rest is picked either by the participants themselves or by the therapist conducting the intake interview. |
|
Experimental: Participant-chosen content, on-demand guidance
Content chosen by participants themselves, guidance upon request from the health care team.
|
The intervention consists of fifteen modules, each having a specific focus on a problem (e.g. comorbid worry alongside the depression) or containing a specific strategy or element (e.g. behavioral activation). The fifteen modules are: Introduction/Psychoeducation about depression, Behavioral activation 1, Behavioral activation 2, Cognitive restructuring, Acceptance, Psychoeducation about emotions, Anxiety and exposure, Comorbid social anxiety, Comorbid worrying and generalized anxiety, Comorbid panic disorder, Sleep problems, Perfectionism, Stress management, Relaxation, and Relapse prevention. The first and last module are assigned to all participants. The rest is picked either by the participants themselves or by the therapist conducting the intake interview. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change on Becks Depression Inventory-II (BDI-II)
Time Frame: Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention.
|
Measure of depressive symptoms.
Possible range for the total sum: 0 to 63 (created by summing up the score from each item).
Clinical ranges for minimal, mild, moderate and severe major depressive disorder are considered to be 0-13, 13-19, 20-28, and 29-63 points.
|
Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention.
|
|
Change on Patient Health Questionnaire (PHQ-9)
Time Frame: Baseline, during week 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 of the intervention, post-intervention (after 11 weeks), 12 months after the end of intervention.
|
Measure of depressive symptoms.
Possible range for the total sum: 0 to 27 (created by summing up the score from each item).
Clinical cut-offs for mild, moderate, moderately severe and severe major depressive disorder are considered to be 5, 10, 15, and 20 points.
|
Baseline, during week 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 of the intervention, post-intervention (after 11 weeks), 12 months after the end of intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change on Generalised Anxiety Disorder 7-item scale (GAD-7)
Time Frame: Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention.
|
Measure of symptoms of generalised anxiety disorder (GAD).
Seven items, the score is interpreted by summing up the score from each individual item.
Higher scores indicate more severe problems with worry and generalised anxiety.
The total sum ranges from 0 to 21 with cut-offs of 5, 10, and 15 representing mild, moderate and severe generalised anxiety.
|
Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention.
|
|
Change on Brunnsviken Brief Quality of Life Scale (BBQ)
Time Frame: Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention.
|
Measure of quality of life, total score ranging from 0 to 96 with a higher score indicating a higher quality of life.
The scores of each of the six primary questions regarding perceived quality of life within an area of life are multiplied with the score of an item measuring the perceived importance of the area in question.
|
Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention.
|
|
Change on Insomnia Severity Index (ISI)
Time Frame: Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention.
|
Measure of insomnia severity and symptoms of disordered sleep.
The total score can range between 0 (no sleep problems) to 28 (severe sleep problems and insomnia).
Norm score ranges include low likelihood of sleep problems (0 to 7 points), some sleep problems (8 to 14 points), moderate sleep problems (15 to 21 points), severe sleep problems (22 to 28 points).
|
Baseline, after the intervention (after 11 weeks), 12 months after the end of intervention.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUNA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Symptoms
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
University of California, San DiegoRecruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Treatment Resistant DepressionUnited States
-
Julia EderNot yet recruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Depressive EpisodeGermany
-
The Royal Ottawa Mental Health CentreNot yet recruitingDepression | Major Depressive Disorder (MDD) | Depressive Episode | Depression - Major Depressive DisorderCanada
-
Finnish Institute for Health and WelfareUniversity of Helsinki; Tampere University; University of Eastern Finland; Strategic...RecruitingMajor Depressive Disorder | Depressive Symptoms Mild to Moderate in SeverityFinland
-
Uppsala UniversityRecruitingPostpartum | Attachment | Depression - Major Depressive DisorderSweden
-
Mental Health Services in the Capital Region, DenmarkHospital del Mar Research Institute (IMIM); Research Centre of the German Foundation... and other collaboratorsEnrolling by invitationDepression - Major Depressive Disorder | Mental DistressSpain, Germany, Denmark
-
Medical Research CouncilKU LeuvenCompletedDepressive Symptoms | Major Depressive DisorderAustralia
-
Massachusetts General HospitalCompletedMajor Depressive DisorderUnited States, China
-
Dr. Nazanin AlaviCompletedDepression | Depressive Symptoms | Major Depressive DisorderCanada
Clinical Trials on Internet-administered Cognitive behavioral therapy (ICBT)
-
Karolinska InstitutetDeakin UniversityRecruiting
-
Karolinska InstitutetVastra Gotaland Region; Region StockholmCompleted
-
Linkoeping UniversityRecruiting
-
Jouf UniversityCompletedPregnant Women | Self Efficacy | Fear of Childbirth | Cognitive Behavioral TherapyEgypt
-
Linkoeping UniversityActive, not recruitingAnxiety Symptoms | Depression SymptomsSweden
-
Karolinska InstitutetRegion StockholmCompleted
-
Umeå UniversityCompleted
-
National Science and Technology Council, TaiwanRecruitingDepression - Major Depressive DisorderTaiwan
-
Region of Southern DenmarkUniversity of AarhusRecruitingAnxiety DisordersDenmark
-
Region SkaneLund UniversityCompleted